Success Story: After RFE, I-140 NIW Approved for a Clinical Medicine Researcher With Our Guidance and Assistance
Client’s Testimonial:
"At first, I was doubting my profile and thinking it wasn’t strong enough to get it. After RFE Chen helped me to restructure every point in my petition. Thank you so much Chen.”
On April 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scholar in the Field of Clinical Medicine (Approval Notice).
General Field: Clinical Medicine
Position at the Time of Case Filing: Research Scholar
Country of Origin: Egypt
State of Residence at the Time of Filing: West Virginia
Approval Notice Date: April 23rd, 2026
Processing Time: 7 months, 8 days (Premium Processing Upgrade Requested)
Case Summary:
A clinical medicine researcher received approval for the I-140 NIW petition after responding to a Request for Evidence. The petition focused on the client’s work investigating vascular diseases, their relationship to cardiovascular and neurological systems, and outcomes in stroke and brain aneurysm patients who require implanted devices.
Credentials Presented in the Petition
- M.B.B.Ch.
- 9 peer-reviewed journal articles, including 1 first-authored article
- 4 abstracts
- 121 citations to the client’s published work
- At least 3 completed peer reviews
Research with Public Health Importance
The petition did not present the client’s work as a narrow clinical interest. Instead, it framed the proposed endeavor as a healthcare-focused research effort with broader national value, especially because vascular disease, stroke, and brain aneurysm outcomes remain significant public health concerns in the United States.
The petition explained that the client’s research can help identify drivers of patient outcomes, support more effective interventions, and improve evidence-based approaches to cardiovascular and neurovascular care. This helped demonstrate that the endeavor had substantial merit and national importance.
Evidence of Independent Recognition
The client’s publication record was used as evidence of sustained research productivity, but the petition went further by explaining how those publications had been evaluated and used by others. The 121 citations were presented as proof that independent researchers had relied on the client’s findings, including work related to gastrointestinal disorders, cardiovascular treatment protocols, infectious disease treatment, and neurological care.
The petition also contextualized citation impact through percentile evidence, noting that several of the client’s papers ranked among highly cited articles in Clinical Medicine for their publication years. This helped show that the citation record reflected meaningful scholarly reliance rather than numbers alone.
RFE Response and Approval
After receiving the RFE, the response emphasized the connection between the client’s clinical medicine background, peer-reviewed research, citation record, peer review service, and future research plans. The petition showed that the client was not only qualified but also well-positioned to continue advancing research that addresses urgent U.S. healthcare needs. We congratulate the client on securing I-140 NIW approval and wish the client continued success in contributing to improved cardiovascular and neurovascular outcomes in the United States.